AI assistant
Sending…
Dermata Therapeutics, Inc. — Director's Dealing 2021
Aug 17, 2021
35467_dirs_2021-08-17_8351344e-622f-46f1-a917-8a25aa371b57.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Dermata Therapeutics, Inc. (DRMA)
CIK: 0001853816
Period of Report: 2021-08-17
Reporting Person: Mento Steven J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-17 | Stock Option (right to Buy) | $7.00 | A | 10000 | Acquired | 2031-08-17 | Common Stock (10000) | Direct |
Footnotes
F1: The option vests in twelve equal monthly installments commencing September 17, 2021.
More from Dermata Therapeutics, Inc.
Regulatory Filings
2026
Jun 4
Capital/Financing Update
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 27
Share Issue/Capital Change
2026
May 22
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Director's Dealing
2026
Mar 17
Board/Management Information
2026
Feb 25
Major Shareholding Notification
2026
Feb 18
Major Shareholding Notification
2026
Feb 17